The Accrual to Clinical Trials (ACT) Network allows researchers to identify an aggregate number of patients that fit their study criteria in under three minutes. Its unique web-based interface facilitates self-directed population searches both locally and at academic medical centers across the United States.
The ACT Network is committed to the goal of adding to the national scientific knowledge base in ways that will inform the scale-up and spread of innovation, which is accomplished with the help of the insights and ideas of partners like the Clinical and Translation Science Institute (CTSI) at the University of Pittsburgh.
Recent developments include an open-access paper in the Journal of Clinical and Translational Science, published in June 2020 by the ACT national dissemination/evaluation workgroup, which includes Pitt CTSI’s Dr. Steven Reis. The paper, summarizing the experiences and outcomes of the first 18 months of the ACT Network national launch, includes learnings from feedback surveys sent in 2019 to local contacts at various ACT Network sites. The dissemination/evaluation team also presented findings from the 2020 hub feedback survey at the annual Dissemination & Implementation Science conference in December 2020.
In November, members of the ACT technology and data harmonization workgroups, including Pitt’s own Michele Morris, Dr. Shyam Visweswaran, and Dr. Steven Reis, presented a poster about ACT’s COVID-19 response at the all-virtual CTSA fall program meeting.
Stay up-to-date on all new developments by subscribing to the ACT Newsletter.